MATERIALS AND METHODS. Upon remodulation of blood flow (reperfusion) in the donor renal transplant, a two-channel microdialysis polyurethane catheter has been implanted in the kidneýs cortex (CMA70, CMA Microdialysis, Sweden). The intracellular substrate (dializate) was collected in special 200 lL vials. The biochemical values have been obtained with the help of CMA 600 Microdialysis (CMA Microdialysis AB, Stockholm, Sweden) analyzer. This research has been conducted over 38 h in the early postoperative period with the biochemical values being read every hour. In the transplant's intertissue space, the following biochemical values were read: glucose, lactate, piruvate, glycerol, and lactate/piruvate ratio. OBJECTIVES. The aim of the study was to determine its incidence and its risk factors in a clinical series at the University Hospital of Liege, Belgium. METHODS. Orthotopic liver transplantations performed from January 2006 until September 2012 were retrospectively reviewed (n = 187). Patients, with no renal replacement therapy (RRT) before transplantation were classified in four groups according to their highest creatinine plasma level during the first postoperative week. First group had a creatinine level below 12 mg/l, the second group between 12 and 20 mg/l, the third group between 20 and 35 mg/l, and the fourth above 35 mg/l. In addition, patients who needed RRT during the first week after transplantation were also classified in the fourth group.
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Preoperative and perioperative parameters were tested as risk factors: age, sex, body mass index (BMI), length of hospital preoperative stay, prior bacterial infection within one month, preoperative ascites, preoperative treatment with ß-blocker, converting enzyme inhibitor, or non steroidal antiinflammatory drugs, preoperative creatinine and bilirubine level, postoperative lactate level, need for postoperative vasopressive drugs, surgical revision, mechanical ventilation for more than 24 h, postoperative peaks in bilirubine and transaminase levels, postoperative hemoglobin level, amount of perioperative blood transfusions, type of immunosuppression. Univariate and multivariate analysis were performed using logistic ordinal regression method. RESULTS. There were 78 patients in group 1 (41.7 %), 46 in group 2 (24.6 %), 38 in group 3 (20.3 %) and 25 in group 4 (13.4 %). Eighteen patients required RRT: 13 (7 %) during the first week after transplantation (group 4), the 5 others after the first week after transplantation (2 in group 1 and 2, and 1 in group 3). There were 7 (3.7 %) early deaths within 28 days after transplantation. Using univariate analysis, the severity of renal dysfunction was correlated with presence of ascites and prior bacterial infection, preoperative bilirubin and creatinine level, need for surgical revision, use of vasopressor, postoperative mechanical ventilation, postoperative bilirubine, transaminase, and hemoglobin levels. The need for transfusion of each type of products also affected renal dysfunction. The ordinal logistic analysis pointed out the BMI (OR = 1.1, p = 0.004), preoperative creatinine level (OR = 11.1, p \ 0.0001), use of vasopressor (OR = 3.31, p = 0.0002), maximal postoperative bilirubine level (OR = 1.44, p = 0.044) and minimal postoperative hemoglobin level (OR 0.059 p = 0.0005). CONCLUSIONS. More than half of liver transplanted patients experienced some degree of early renal dysfunction after transplantation. Risk factors are preoperative renal dysfunction, and mainly perioperative circulatory instability requiring the use of vasopressor and postoperative anemia. RESULTS. The plasma volume expansion was greater in the colloid group, compared to the crystalloid group, as indicated by significantly lower haematocrit and CaO 2 , and higher cardiac filling pressures. Urine flow increased significantly (170 %) only in the crystalloid group. Cardiac index and RBF increased by 15 % respectively 5-10 %, in both groups (ns). In neither one of the groups did plasma volume expansion render a change in RDO 2 . GFR increased to a similar extent with both fluids. In the crystalloid group, there was a significant increase in both RVO 2 and RO 2 Ex, which was not seen in the colloid group (see figure) .
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[ The common side effect of colistin is nephrotoxicity, 14 %-55 % reported. Risk factors for nephrotoxicity are advanced age, nephrotoxic agent usage and chronic renal failure in general population. OBJECTIVES. The aim is to identify the risk factors for acute kidney injury in sepsis patients treated with colistin. METHODS. Gram-negative sepsis patients admitted to ICU in two years were analyzed retrospectively. APACHE II, the presence of shock, initial glomerular filtration rate, the duration of colistin administration, simultaneous nephrotoxic agent administration (NSAID, antibiotics) were recorded. Acute renal injury was classified according to RIFLE criteria. Patients with chronic renal failure were excluded. RESULTS. 64 (32 male, 32 female) gram-negative sepsis patients were evaluated. Acute kidney injury was detected in 56 (87 %) patients. 42 patients out of 56 were administered colistin and the mean duration of administration was 6,43 days. The distribution of acute kidney injury in patients using colistin is given in Table 1 . Acute kidney injury was significantly higher in colistin, nephrotoxic agent, shock (+) patients compared to colistin, nephrotoxic agent (+) shock (-) patients (p:0,049). In the presence of shock, acute kidney injury was higher in patients using colistin but not nephrotoxic agent according to patients without shock (p:0,023). In septic shock patients using colistin, there is no difference in acute kidney injury between patients with nephrotoxic agent and without nephrotoxic agent usage (p:0,367). 57 % of the patients using colistin who developed acute kidney injury were in the Failure (F) group according to RIFLE criteria. Acute kidney injury was significantly higher in septic shock patients who were using colistin compared to septic shock patients who were not using colistin (p:0,0001). CONCLUSIONS. The incidence of acute kidney injury classified according to RIFLE criteria is high in sepsis patients. New onset acute kidney injury is correlated with the presence of shock and colistin usage but not with simultaneous nephrotoxic agent usage. The presence of shock is a risk factor for acute kidney injury in sepsis patients treated with colistin. 
